Julia G. Butchko, Chief Development & Technology Officer at Immunovant, Inc. (IMVT), sold 120,961 shares at $16.79 ($2.0M) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $2.0M IMVT by Chief Development & Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.16 | 19 | $288 | 0.0% |
| 2 | $16.79 | 60,471 | $1.0M | 50.0% |
| 3 | $16.79 | 60,471 | $1.0M | 50.0% |
| Total | $16.79 avg | 120,961 | $2.0M | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |